Negative Data on Seroquel Allegedly Suppressed by Drugmaker AstraZeneca PLC

Published: Mar 02, 2009

WASHINGTON, Feb 27 (Reuters) - AstraZeneca PLC (AZN.L) failed to warn physicians and patients about risks associated with its widely used schizophrenia drug Seroquel, plaintiffs' attorneys said on Friday.

Back to news